Medication questions on the LCSW and LMSW exams are not pharmacology questions. Social workers do not prescribe, and the items test whether you recognize a drug class, a side effect or an emergency in a vignette, and whether you do the right thing next: ask, notice, and get the information to the prescriber or to medical care. Common medications and their side effects sit on all four 2026 ASWB outlines.
This is about how the exam tests the topic, and it is not medical advice. If you take any of these medicines, follow your prescriber's advice and do not stop or change a dose on your own. In an emergency, call 911; if you or someone you know is thinking about suicide, call or text 988.
The drug classes in one table
| Class | Examples (generic, brand) | Used for | What items turn on |
|---|---|---|---|
| SSRIs | Fluoxetine (Prozac), sertraline (Zoloft), escitalopram (Lexapro), paroxetine (Paxil) | Depression and anxiety disorders | Weeks to work; suicidality warning under 25; taper, do not stop abruptly |
| SNRIs | Venlafaxine (Effexor XR), duloxetine (Cymbalta) | Depression and anxiety disorders | The same antidepressant warnings |
| Other newer antidepressants | Bupropion (Wellbutrin), mirtazapine (Remeron) | Depression | The same antidepressant warnings |
| Older antidepressants | Tricyclics such as amitriptyline; MAOIs such as phenelzine (Nardil) | Depression | More side effects; MAOIs and tyramine-rich foods |
| First-generation antipsychotics | Haloperidol (Haldol) | Schizophrenia and other psychoses | Tardive dyskinesia and neuroleptic malignant syndrome, both possible with any antipsychotic |
| Second-generation antipsychotics | Risperidone (Risperdal), olanzapine (Zyprexa), quetiapine (Seroquel), aripiprazole (Abilify), clozapine (Clozaril) | Schizophrenia, bipolar disorder | Weight, blood sugar and lipids; clozapine blood counts |
| Mood stabilizers | Lithium; anticonvulsants such as divalproex (Depakote), carbamazepine (Tegretol), lamotrigine (Lamictal) | Bipolar disorder | Lithium toxicity and blood levels |
| Benzodiazepines | Alprazolam (Xanax), lorazepam (Ativan), clonazepam (Klonopin), diazepam (Valium) | Anxiety, short term | Dependence; dangerous withdrawal; opioids plus benzodiazepines |
| Buspirone | Buspirone | Anxiety | Daily for weeks before it works; not as needed |
| Stimulants | Methylphenidate (Ritalin, Concerta), amphetamines (Adderall, Vyvanse) | ADHD, narcolepsy | Misuse and diversion; never shared |
| Opioid use disorder | Methadone, buprenorphine (alone or with naloxone, as in Suboxone), naltrexone (Vivitrol) | Opioid use disorder | All three FDA-approved and effective |
| Overdose reversal | Naloxone (Narcan) | Opioid overdose | Reverses it fast; sold over the counter |
| Alcohol use disorder | Naltrexone, acamprosate, disulfiram | Alcohol use disorder | What each one does |
Learn the classes, one or two names in each, and both the brand and generic names, because a vignette can use either.
Antidepressants
NIMH says antidepressants usually take four to eight weeks to work, and lists upset stomach, headache and sexual dysfunction as common side effects of SSRIs and other antidepressants. Two warnings matter most for the exam.
The suicidality warning. Antidepressant labels carry a boxed warning that antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents and young adults in short-term studies, and they tell clinicians to monitor everyone taking them closely. NIMH puts the age at under 25 and says it shows especially in the first few weeks after starting or after a dose change. On the exam, a young client who recently started an antidepressant and is newly agitated or talking about suicide gets a risk assessment and the prescriber's involvement, not reassurance.
Stopping. Labels recommend reducing the dose gradually rather than stopping abruptly, because stopping suddenly can bring dizziness, nausea, irritability and other symptoms. A client who wants to stop should talk to the prescriber first.
The older antidepressants come with more side effects, NIMH says. MAOIs add one the exam likes: foods high in tyramine, such as smoked or aged meats, fish and cheeses and some alcoholic drinks, can cause a serious reaction, so diet is part of taking them.
Antipsychotics
NIMH links tardive dyskinesia, uncontrollable movements that can range from mild to severe, to long-term use of first-generation antipsychotics, also called typical antipsychotics or neuroleptics. It is not only a first-generation risk, though: the label for risperidone, a second-generation drug, warns that these potentially irreversible movements may develop with any antipsychotic. Second-generation, or atypical, antipsychotics also bring metabolic changes, higher blood sugar, abnormal lipids and weight gain, so NIMH says people taking them may be asked to monitor weight, glucose and lipids regularly.
Two more facts come up. All antipsychotics carry a boxed warning that older adults with dementia-related psychosis who take them are at increased risk of death. And clozapine requires regular blood tests for a dangerous drop in a type of white blood cell, which NIMH says occurs in 1% to 2% of people. FDA removed the separate federal reporting program for clozapine effective June 13, 2025, but says prescribers should keep monitoring blood counts as the label directs.
Mood stabilizers
Lithium treats mania and bipolar disorder, and its warning signs are worth knowing in detail. Its label's boxed warning is that toxicity can occur at doses close to therapeutic levels, so lithium blood levels, and kidney and thyroid function, are checked regularly. The label lists mild signs of toxicity such as fine tremor, lightheadedness, lack of coordination and weakness, along with nausea, vomiting and diarrhea, and more serious ones such as slurred speech, confusion and seizures. MedlinePlus adds that fluid and salt intake matter, that severe diarrhea, heavy sweating or fever should be reported, and that common pain relievers such as ibuprofen and naproxen, and diuretics, can interact with it.
Some anticonvulsants, such as divalproex, carbamazepine and lamotrigine, are also used as mood stabilizers, and NIMH says people taking them are monitored for levels, side effects and interactions too.
Anxiety medications
Benzodiazepines relieve anxiety, but NIMH says taking them over long periods can lead to tolerance and dependence, so they are usually prescribed for short periods and tapered slowly. In 2020 FDA required their boxed warning to cover abuse, misuse, addiction, physical dependence and withdrawal, and warned that stopping abruptly or cutting the dose too fast can cause withdrawal reactions, including seizures, that can be life-threatening. FDA also warns that combining benzodiazepines with opioids or other depressants of the central nervous system has caused severe breathing problems and death.
Buspirone is different: NIMH says it must be taken every day for three to four weeks to reach its full effect, and it does not work on an as-needed basis.
ADHD stimulants
Methylphenidate and amphetamines treat ADHD and narcolepsy. In May 2023 FDA required their boxed warning to describe the risks of misuse, abuse, addiction and overdose consistently across the class, and added that patients should never share their prescription stimulants with anyone. A vignette about a student selling or sharing a prescription is about that risk.
Medications for substance use disorders
FDA has approved three medications for opioid use disorder: methadone, buprenorphine and naltrexone, and calls all three safe and effective. NIDA describes how they differ. Methadone activates the same receptors as other opioids, but more slowly and for longer; buprenorphine activates them to a lesser degree; both reduce withdrawal and cravings. Naltrexone blocks the receptors instead, so opioids can no longer cause feelings of pleasure. Naloxone reverses an opioid overdose rapidly, and since March 29, 2023 a naloxone nasal spray has been approved for sale over the counter.
For alcohol use disorder, NIAAA lists three approved medications: naltrexone, which helps reduce the urge to drink; acamprosate, which eases the negative symptoms some people feel during abstinence; and disulfiram, which causes unpleasant symptoms if the person drinks.
On the exam, medication for a substance use disorder is treatment, not a failure of recovery, and an option that dismisses it is unlikely to be the key.
The emergencies to recognize
Each of these needs prompt medical attention, and on the exam, safety comes before any other step.
- Serotonin syndrome, most often when drugs that raise serotonin are combined, though one alone can cause it: agitation or confusion, a fast heart rate, sweating, fever, tremor, muscle stiffness, nausea and diarrhea.
- Neuroleptic malignant syndrome, with antipsychotics: high fever, muscle rigidity, altered mental status and unstable vital signs. The label calls it potentially fatal.
- Lithium toxicity: the signs above, from tremor and stomach upset to confusion, especially after illness or dehydration.
- Benzodiazepine withdrawal after stopping suddenly, which can include seizures.
- Opioid overdose: naloxone and a 911 call.
- New or worse suicidal thinking soon after starting or changing an antidepressant: assess risk and involve the prescriber or emergency care.
Your role, and how items test it
- You do not prescribe or advise on doses. NIMH tells people not to stop a prescribed medication even when they feel better, and the exam expects you to send any question about stopping or changing it to the prescriber.
- Ask. Is the client taking it as prescribed? Any side effects? Other medicines, supplements or herbal remedies? Why did they stop?
- Explore the reasons. Cost, side effects, stigma and beliefs about medication are all reasons people stop, and motivational interviewing fits ambivalence about medication as well as about drinking.
- Communicate, with consent. Getting information to the prescriber needs the client's agreement, except where safety requires otherwise.
- Rule out the physical first. In one of ASWB's Guidebook sample questions, a hospitalized patient on psychotropic medication and an anticonvulsant has been drowsy, stumbling and slurring for days. The FIRST step is to consult the psychiatrist for a medication evaluation, and ASWB says checking for hidden substance use comes only after that. Biopsychosocial assessment covers why the biological domain comes first when the body gives a cue.
Typical wrong answers tell the client to restart or stop a medication, reassure them that a side effect is normal, or explore the psychological meaning of a symptom that could be a drug reaction.
How to study it
- Learn the classes and a name or two in each, generic and brand.
- Learn the warnings and emergencies above, because that is where most items sit.
- Practice the role. Most medication items are really about the order of steps: safety, then asking, then the prescriber. The qualifier words and the LCSW exam cheat sheet cover that order.
- Do not memorize doses or full side-effect lists. No item needs them, and the time is better spent on the rest of the outline, which how to pass the LCSW exam maps.
Our Assessment Practices chapter has a full lesson on medications and their side effects, the DSM-5-TR post covers the diagnoses these medications treat, and the free quiz mixes in questions from across the outline.
Read at source on October 22, 2026, and rechecked on October 23: NIMH, Mental Health Medications (last reviewed December 2023); the FDA labels for Zoloft (revised August 2023), lithium carbonate (revised July 2025) and Risperdal Consta (revised January 2025) on DailyMed; FDA Drug Safety Communications on benzodiazepines (September 23, 2020), prescription stimulants (May 11, 2023) and clozapine (August 27, 2025); FDA's page on medications for opioid use disorder and its March 29, 2023 approval of over-the-counter naloxone; NIDA, Medications for Opioid Use Disorder (March 2025); NIAAA, Treatment for Alcohol Problems (February 2025); MedlinePlus drug information for lithium and phenelzine; and ASWB's August 2026 Examination Guidebook. This is educational content about the exam, not medical advice. ASWB Master is not affiliated with, endorsed by or approved by the Association of Social Work Boards.